Phathom Pharmaceuticals, Inc. PHAT Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s net income?
- Phathom Pharmaceuticals, Inc. (PHAT) reported net income of -$30.37M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s net income changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s net income increased by 67.8% year-over-year, from -$94.32M to -$30.37M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s net income has grown at a 11.4% compound annual growth rate (CAGR), from -$143.88M to -$221.25M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.